Strata Skin Sciences
| Company type | Public |
|---|---|
| Nasdaq: SSKN | |
| Founded | 1 January 1989  |
| Headquarters | Horsham, Pennsylvania, Pennsylvania , United States |
| Website | strataskinsciences.com |
Strata Skin Sciences (formerly MELA Sciences, Inc.)[1] is an American medical device company focused on the design, development and commercialization of non-invasive tools to provide additional information to dermatologists during melanoma skin examinations.
The company’s flagship product, XTRAC®, is a medical device that allows for a trained dermatologist to treat skin conditions like Vitiligo and Psoriasis with monochromatic UV Light. Following completion of a successful conformity assessment procedure, Strata Skin Sciences has also been granted CE Mark approval for sale of MelaFind® in the European Union.[2]
In July 2015, the company acquired PhotoMedex Inc. and is planning to relocate its headquarters from Irvington, New York to Horsham, Pennsylvania in Montgomery County.[3]
References[edit]
- ^ "Mela Sciences, no more; Company rebrands as Strata Skin Science". MassDevice. 2015-12-22. Retrieved 2021-02-19.
- ^ "Case - Mela Sciences Inc". Pomeranz Law. Archived from the original on 26 September 2013. Retrieved 17 November 2012.
- ^ George, John. "Exclusive: N.Y. medical device firm moving to Montco" Philadelphia Business Journal (July 15, 2015)
 | This article about a corporation or company specializing in health technology is a stub. You can help Wikipedia by expanding it. |